1 Followers
24 Following
sagarj1030

Healthcare Outlook

Trending Updates About Healthcare, Medical Devices, Pharmaceutical etc.

Capnography Devices Market Size will Grow Profitably in upcoming Estimation year 2026

Capnography is the process of extensive measurement and display of concentrations or partial pressures of carbon dioxide (CO2) in the respiratory gases by using a capnograph. It accurately measure the levels of carbon dioxide released into the bloodstream. The readings are presented as a graph of expiratory CO2 plotted against time or expired volume called as capnogram. A capnogram is direct monitoring of inhaled and exhaled concentrations of CO2 and an indirect monitoring of CO2 in arterial blood. There is a very small difference in pressure between arterial blood and exhaled CO2 among healthy individuals. On the other hand, a large difference between arterial blood and exhaled gas, sometimes exceeding 1kPa, is observed in people suffering from various forms of lung diseases and some forms of congenital heart diseases.

 

Download PDF Brochure of This Business Report @ https://www.coherentmarketinsights.com/insight/request-pdf/433

 

Capnography majorly depicts all the three components of respiration: metabolism, transport, and ventilation and therefore gives an excellent picture of the respiratory process. This is a major help for people who suffer from asthma and chronic obstructive pulmonary disease (COPD) as it will help in proper patient monitoring and take further medications accordingly. The American Society of Anesthesiologists (ASA) endorses end-tidal capnography as a standard of care for general anesthesia, deep sedation and moderate sedation. Other specialties include critical care and emergency medicine.

 

Rising demand for effective monitoring of carbon dioxide levels was limited due to involvement of pulse oximetry, which takes 4-5 minutes to reflect respiratory status of the individual while capnographs provides the ventilation status of individuals in real time, thereby improving patient care. According to the American Thoracic Society, approximately 360,000 respiratory failure cases every year are observed in the U.S., and of this 36% of deaths occur during hospitalization, 30% of individuals die post-surgery and up to 7% of all Medicare individuals among them in 2014 were indicated with respiratory compromise--a state characterized by respiratory failures, insufficiency, respiratory arrest or death.

 

Market in emerging economies is expected to augment on account of recommendations by global and government healthcare organizations

 

North America dominates the global capnography devices market due to rampant development of advanced products in the region. Latin America capnography devices industry is experiencing a significant growth majorly due to the recommendations to use capnography in routine hospital settings by esteemed organizations and government bodies. The World Health Organization (WHO) published a report on safe surgery in 2009 that recommended the use of capnography monitoring devices during endotracheal tube placement, hypoventilation and esophageal intubation for better possible outcomes in patients. The Uruguayan Society of Anesthesiologists and the American Society of Anesthesiologists also recommends the usage of capnography monitoring in routine-use during procedural sedation and anesthetics. These guidelines by the organizations substantiate the importance of capnography equipment in hospital use.

 

Product innovation by market players contributing towards capnography devices market growth

 

Key players in capnography devices market include Dragerwerk AG & Co. KGaA., Welch Allyn, Inc., Smiths Medical, Medtronic, Inc., Philips Healthcare, Masimo, Nonin Medical, Inc., Nihon Kohden Corporation, CareFusion Corporation and Dia Medica, Inc.

 

Capnography Devices Market Taxonomy:

 

On the basis of technology, the global market is classified into:

 

Capnographs

- Mainstream capnographs

- Sidestream capnographs

- Microstream capnographs

Disposables

 

On the basis of device type, the global market is classified into:

 

Handheld

Stand-alone

Others

 

Browse In-Depth Analysis Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/capnography-devices-market-433

 

About Coherent Market Insights:

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

Contact Us:

 

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Needle-free IV Connectors Market To Witness Considerable Growth From 2017 To 2025

Needle-Free IV Connectors are routinely used in the hospitals for intravenous administration of fluids and medicines to protect the hubs in vascular access systems. In order to reduce risks of possible contaminations associated with the IV administration and to curb manipulation as much as possible, needle free IV connectors can prove to be ideal in all types of IV infusions. Furthermore, technological advancements such as connectors that prevent fluid reflux, highly closed systems, and connectors embedded with antimicrobial agents (V-Link) have helped to decrease the risk of bloodstream infections associated with IV administration. Needle-free connectors are with extended dwell time that can help preventing intraluminal contamination and device cross-contamination, which can be favorable for the growth of the market in the near future.

 

Get In-Depth Sample Copy of This Report @ https://www.coherentmarketinsights.com/insight/request-sample/426

 

Market Dynamics

 

Government organizations and regulatory bodies namely Centers for Disease Control and prevention (CDC) have recommended the usage of needle-free connectors to reduce the incidence of sharp injuries and blood stream infections mandating its usage in medical facilities in the ‘Guidelines for the Prevention of Intravascular Catheter-Related Infections’ in 2011. Major issues associated with the conventional options of intravenous infusion are contamination from external sources during administration, blood reflux, and risk of bloodstream infections, which are addressed by needle-free IV connectors. The National Healthcare Safety Network (NHSN) conducts various programs worldwide that helps to impart education and hands on training sessions to all physicians and nurses about the usage of needle-free connectors and insertion of central venous catheters in children and adults. The advantages of needle-free IV connectors over conventional IV administration namely, safer access to IV lines without using needle, reduced risk of bloodstream infections and reduced possibility of contamination, rising chronic diseases prevalence and cost containment through use of needle-free IV connectors is expected to boost the growth of needle-free IV connectors market over the forecast period.

 

The global needle-free IV connectors market was valued at US$ 621.1 million in 2016 and is expected to reach a robust CAGR of 10.3% over the forecast period (2017-2025).

 

Rising incidence and prevalence of various chronic diseases and need for treatment is expected to boost the needle-free connectors market

 

North America accounts for the largest share in the global needle-free connectors market, followed by Europe. This is mainly attributed to the rise in the geriatric population and chronic diseases. According to the Centers for Disease Control and Prevention (CDC), 2016, about half of American adults, that is around 117 million people had one or more chronic health conditions and one in four adults had two or more chronic health conditions. The factors driving the growth of the needle-free IV connectors market includes government investments and funding to improve healthcare infrastructure, awareness in people, and healthcare practitioners.

 

Competitive Landscape

 

Some major players operating in the needle-free IV connectors market are Baxter International Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, CareFusion Corporation, ICU Medical, Inc., Nexus Medical LLC, RyMed Technologies, LLC, and Vygon SA.

 

Detailed Segmentation:

 

Global Needle-Free IV Connectors Market, By Design Type:

Simple

Complex

 

Global Needle-Free IV Connectors Market, By Mechanism:

Positive

Negative

Neutral

 

Global Needle-Free IV Connectors Market, By Dwell Time:

Seven-Day

Other than Seven-Day

 

Browse Complete Report @ https://www.coherentmarketinsights.com/market-insight/needle-free-iv-connectors-market-426

 

About Coherent Market Insights:

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

Contact Us:

 

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Autoimmune Disease Diagnostics Market Perspective with Study of Leading Players 2018 - 2026

The immune system of human body recognize some invaders such as bacteria, viruses, and external chemicals and attacks those to protect the body. However, sometimes the immune system attacks the healthy cells of body by considering them as foreign cells. Such a condition is called autoimmune disease. The autoimmune disease causes abnormal organ growth and changes in organ function. The genes of an individual with environmental exposure might be the major reason for autoimmune disease development. Some of the common autoimmune diseases among over 80 types of autoimmune diseases are type 1 diabetes, systemic lupus erythematosus, inflammatory bowel disease, rheumatoid arthritis. The curing therapy for autoimmune diseases is not yet available only relieving treatments are available for this diseases. Diagnosis of the autoimmune diseases can be done by the tests which involves antinuclear antibody test, antibody test, complete blood counts and some others.

 

Get Access on Research Analysis and Growth Strategy: https://www.coherentmarketinsights.com/insight/request-sample/419

 

The growing incidences of autoimmune diseases and government initiatives to boost the autoimmune disease diagnostics market

 

According to American Autoimmune Related Disease Association (AARDA), in 2016, around 50 million people suffered from autoimmune diseases in the U.S. with 75% being women. Increasing incidence of autoimmune diseases, rising public awareness and government initiatives taken to spend the budget on diagnosis and care services for autoimmune diseases, are some of the factors which are driving the autoimmune disease diagnostics market. Many of the organizations and governments are funding the research and development program for autoimmune diseases, this will help to launch the new products in the market and definitely help in the growth of autoimmune disease diagnostics industry. For instance, the discovery of novel biomarkers, which has proven to be significant to improve the diagnosis of autoimmune diseases is also one of the major factor driving the autoimmune diseases diagnostic market.

 

The technological advancements in the North America region driving the autoimmune disease diagnostics market

 

The regional segmentation of autoimmune disease diagnostics market by Coherent Market Insights comprises North America, Europe, Asia Pacific, Africa and rest of the world. North America is of the largest revenue contributor in the global autoimmune disease diagnostics industry. This is mainly attributed to rising incidence of some of the common autoimmune diseases like rheumatoid arthritis and type1 diabetes. The increase in funding by government and private sector, increasing regulatory scenario monitored by World Health Organization (WHO), and technological advancements are some of the factors which are driving growth of the autoimmune disease diagnostics market in the North America region. Asia Pacific is projected to be a fast emerging region in the global autoimmune disease diagnostic market.

 

The introduction of novel biomarkers in the market will aid in the growth of autoimmune disease diagnostic market

 

The key players operating the autoimmune disease diagnostics market are Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, Euroimmun, Inova Diagnostics, Roche Diagnostics, Siemens Healthcare, A. Menarini Diagnostics, Adaptive Biotechnologies, AESKU Diagnostics, and many others. The government agencies of various countries are increasing their healthcare spending to provide better health care services, and the introduction of novel biomarkers in the research area, owing for ample opportunity for the key players, which in-turn will boost the autoimmune diseases diagnostic market.

 

Aging population and technological advancements in diagnosis of rheumatoid arthritis will be the cause of growth for rheumatoid arthritis segment

 

The global autoimmune disease diagnostic market are segmented on the basis of disease type, test type, end user and geography

 

On the basis of disease type, the autoimmune disease diagnostic market is segmented into:

 

Systemic Autoimmune Disease diagnostics

Rheumatoid Arthritis

Ankylosing Spondylitis

Systemic Lupus Erythematosus

Some Others

Localized autoimmune disease diagnostics

Multiple Sclerosis

Type 1 diabetes

Hashimoto’s thyroiditis

Idiopathic Thrombocytopenic purpura

 

Browse In-Depth Analysis Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/autoimmune-disease-diagnostics-market-419

 

About Coherent Market Insights:

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

Contact Us:

 

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Arthroscopy Devices Market Analysis of Future Trends and Growth Opportunities 2025

Arthroscopy is a minimally invasive surgical procedure performed by surgeons to visualize, diagnose and treat the joint related disease. The surgeon makes a small incision through which they insert the probe contain a small lens and lightening system to visualize the inside structure. The arthroscopic surgery is performed to treat the acute or chronic injury related to knee, shoulder, hip and wrist by avoiding post-surgery complications, infection and appears minimum scars at surgery site. There are various applications of arthroscopy devices in knee, shoulder and hip implantation and among these knee implantation contributes the major market share followed by shoulder implantation supported by the increase in cases of knee and shoulder replacement surgery procedures worldwide due to increase in number of obese and aging population.

 

Download Free PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/412

 

Market Dynamics

 

Rapid advancements in technology has led to increasing adoption of arthroscopy devices, in turn creating a highly conducive environment for growth of the market. It is expected that North America and Asia-Pacific region will show high growth rate during the forecast period, mainly due to increasing geriatric population and growing number of injuries necessitating knee and shoulder surgery. The surgery is especially preferred by sportspersons, due to its low recovery time and minimally-invasive nature. Also, the growth is supported by increased rate of knee surgery. The leading cause behind increased rate of joint pain is overweight and aging population.

 

High cases of joint replacement surgery is leading the growth of arthroscopy devices market in North America

 

Increasing incidence of joint replacement in North America is providing opportunity for the growth of arthroscopy devices market. According to Canadian Institute for Health Information (CIHI), around 113,000 knee and hip surgeries are performed in Canada annually. According to the same source, during the period 2009 to 2015, knee replacement surgery and hip replacements surgery increased by 20.3% and 20% respectively. According to Centers for Disease Control and Prevention (CDC), in the U.S. during 2013-2015 nearly 54.4million adults were diagnosed with arthritis and it is expected to reach 78.4million by 2040. These instances will increase the sale of arthroscopy devices in the near future.

 

The global arthroscopy devices market was valued at US$ 3,910.7 million in 2016 and is expected to witness a robust CAGR of 5.4% during the forecast period (2017 – 2025).

 

Competitive Landscape

 

Key companies covered as a part of this study include Smith & Nephew, Olympus Inc., Karl Storz, Stryker Corporation, CONMED Corporation, Vimex Sp. z o.o. and DePuy Synthes Inc.

 

Detailed Segmentation:

 

Global Arthroscopy Devices Market, By Product Type:

Arthroscopes

Arthroscopy Shavers

Arthroscopy Fluid Management System

Arthroscopy Implants

Arthroscopy Radio Frequency Systems

Arthroscopy Visualization Systems

 

Global Arthroscopy Devices Market, By Therapeutic Application:

Knee Implants

Shoulder Implants

Hip Implants

Others

 

Browse In-Depth Analysis Research Report @ https://www.coherentmarketinsights.com/market-insight/arthroscopy-devices-market-412

 

About Coherent Market Insights:

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

Contact Us:

 

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Electronic Health Record (EHR) Systems Market Report For 2018 Explored In Latest Research

The systems that are used to maintain digital health record of the patient are called electronic health record (EHR) systems. This systems supports the systematic storage of information such as health progress notes, diagnoses, vital signs, medications, allergies, lab data and past medical history. The electronic storage of the system helps the ecofriendly storage of the information with minimum risk of losing it along with less manual work and other facilities such as easy access to the required information.

 

Download PDF Brochure of This Business Report @ https://www.coherentmarketinsights.com/insight/request-pdf/403

 

The EHR systems helps to access and track health records conveniently and also allows for easy sharing of patient information with other healthcare professionals, in order to take clinical decisions during the treatment. Furthermore, the system also helps to get connect with different locations and healthcare departments to collect patient data; for instance, from clinical laboratory, other hospitals, in schools for maintaining student’s health record, different companies that keeps the health record of their employees, pharmacies, and emergency facilities. For effective use and to avoid reimbursement loss from any treatment some EHR system providers follow some methods to guide the patient and clinician during the course of treatment.

 

Technological advancements, highly beneficial applications and raised demand of EHR systems lead the growth for Electronic health record (EHR) systems market towards positive direction in the near future

 

The continuous improvements in healthcare sector and supportive government initiatives create a highly conducive environment for growth of the global electronic health record (EHR) systems market. For instance, the American Recovery and Reinvestment Act of 2009 authorizes the Centers for Medicare & Medicaid Services (CMS) to provide incentive payments to eligible professionals (EPs) and hospitals who adopt, implement, upgrade, or demonstrate meaningful use of certified electronic health record (EHR) technology. The top contributor region in this market is North America, followed by Europe, as this regions has high adoption rate and developed healthcare network and facilities. The increasing development and digitalization in emerging economies are expected to show the high growth rate in electronic health record (EHR) systems industry in the near future.

 

Competitive Landscape

 

Some of the major players in the electronic health record (EHR) systems market are Cerner Corporation, athenahealth, Inc, Meditech, Allscripts, Epic Systems Corporation, Quality Systems Inc, McKesson Corporation and GE Healthcare. Other emerging players in this market are Healthcare Management Systems, eClinicalWorks, Healthland and CureMD Research & Development. Also, the earliest acquisition in this market is Cerner Corporation acquired Siemens Health Services in February 2015. This acquisition will drive the innovation and development in healthcare IT segment.

 

Electronic health record (EHR) systems market taxonomy:

 

Global Market by Product Type

 

Client Server-based EHR Systems

Web/Cloud-based EHR Systems

 

Global Market by End User

 

Hospitals

Ambulatory Care Centers

 

Browse In-Depth Analysis Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/electronic-health-record-ehr-systems-market-403

 

About Coherent Market Insights:

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

Contact Us:

 

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Peripheral Vascular Devices Market Projections, Insights & Growth Forecast By 2026

Peripheral vascular disease (PVD), also known as arteriosclerosis obliterans, arterial insufficiency of the legs, claudication, or intermittent claudication, is a blood circulation disorder that causes the blood vessels in the heart or brain to narrow, spasm or block. Peripheral vascular disease usually causes fatigue and pain in the legs and particularly during strenuous physical activities, which usually subsides with rest. The blood vessels supplying oxygenated blood to the arms, kidneys, intestines, and stomach are usually affected by the peripheral vascular devices. According to the Center for Disease Control and Prevention, around 12 to 20 percent of the population in the age category of 60 years and above, developed PAD, in 2016. The incidence rate of this disease is steadily increasing.

 

Download Free PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/391

 

North America held the maximum market share in the global peripheral vascular devices market in 2016. The dominance of this region is attributed to the high adoption of minimally invasive surgeries, high healthcare expenditure as well as patient awareness, among others. Asia Pacific is likely to grow at maximum rate over the forecast period. Presence of a large patient pool with unmet medical need is expected to be a major driver for growth of the market in this region. Improving healthcare scenario in emerging economies such as India and China, among others coupled with the growing GDP of these countries and increasing government initiatives are aiding the growth of the peripheral vascular devices market in this region.

 

Growing geriatric population to drive the market growth

 

Growing geriatric population, which is highly susceptible to chronic diseases is expected to create a conducive environment for growth of the peripheral vascular devices market. Additionally, presence of unexploited growth opportunities in the emerging markets such as China, India, and Brazil coupled with rising health awareness among the population are also expected to boost growth of the market in the coming years.

 

Increasing adoption of bio-absorbable stents coupled with increasing health awareness and growing disposable income among the populace create immense opportunities for the manufacturers in the market. Nonetheless, the high costs of these procedures, particularly in emerging economies and product failures are key challenges faced by vendors.

 

Top Key Players

 

Some of the major companies operating in the global peripheral vascular devices market are Abbot Laboratories, Boston Scientific Corporation, Angioscore, Emboline INC, and Bayer AG.

 

Peripheral vascular devices market taxonomy

 

On the basis of product type, the global market is segmented into:

 

Angioplasty Balloons

Embolic Protection Devices

Stents

Inferior Vena Cava Filters

Synthetic Surgical Grafts

Aortic Stent Grafts

Peripheral Vascular Accessory Devices

Vascular Closure Devices

PTA Balloon Catheters

Chronic Total Occlusion (CTO) Devices

 

Browse In-Depth Analysis Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/peripheral-vascular-devices-market-391

 

About Coherent Market Insights:

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

Contact Us:

 

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Biomedical Refrigerators Market Analysis and Development Trends 2018-2026

Biomedical refrigerators are medical equipment used for storing various biological samples such as biological reagents, medicines, vaccines, blood, blood derivatives, deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and flammable chemicals. Samples with biological origin require accurate conditions for effective storage, which is more effectively provided by biomedical refrigerators in compared with domestic refrigerators. Samples of biological origin are usually available in blood banks, research laboratories, hospitals, educational institutes, and diagnostic centers. Biomedical refrigerators maintain hygiene and consistent temperature in order to reduce the risk of bacterial contamination and explosions of unstable materials, due to which these refrigerators are widely used in blood banks, biomedical laboratories and hospitals. Biomedical refrigerators feature distinct compartments so as to prevent cross contamination and can hold a variety of medical supplies such as blood or vaccines.

 

Get In-Depth Sample Copy of Research @ https://www.coherentmarketinsights.com/insight/request-sample/381

 

Escalating demand for cellular therapies, blood transfusions, organ transplant, and biopharmaceuticals is stimulating growth of the biomedical refrigerators market. In addition, increasing biomedical R&D activities is boosting demand for biomedical refrigerators, to store biological samples. However, presence of large number of local players and increasing use of renewed equipment are some of the factors hampering growth of the global biomedical refrigerators market. Rampant advancements in technology and infrastructural upgrade of clinics, hospitals, and research laboratories, is expected to fuel growth of the global biomedical refrigerators market over the forecast period.

 

Factors such as increasing importance on energy-efficient refrigerators are driving the prospects for growth of the biomedical refrigerators market. A major challenge faced by the market includes reduction in energy consumption. According to the current standards, refrigerants are required to have minimum global warming potential, an ozone depleting potential of zero, and be nontoxic as well as inflammable. It is highly challenging to adhere to these standards while maintaining a stable temperature control. Therefore, manufacturers are focusing on developing technologies to maximize efficiency and temperature consistency, while minimizing heat and energy consumption. Improvement of healthcare infrastructure due to the increasing support from government and industry participants to provide technical and financial assistance in procurement of biomedical refrigerators is a positive trend witnessed in the market. These factors in turn, are expected to boost growth of the market in the near future.

 

North America holds the maximum market share, majorly attributed to presence of high quality standards and high expenses on hospital and healthcare infrastructure in the region. The U.S. spends major share of its GDP toward healthcare, with an aim to improve patient care, reduce the wastage of pharmaceutical and biological components. Growing prevalence of chronic diseases coupled with increasing geriatric population, is triggering research and development that requires appropriate biomedical storage of samples. This is significantly driving the number of blood transfusion procedures, consumption of various pharmaceutical products. This in turn, is boosting demand for biomedical refrigerators across all the end-use segments. Emerging economies such as India, China, and Indonesia are increasingly boosting the expenditure on healthcare infrastructure and medical services.

 

Major Key Players

 

Key players operating in the global biomedical refrigerators market include Thermo Fisher Scientific, Aegis Scientific, Inc., Panasonic Healthcare Co. Ltd., Eppendorf AG, Terumo Corporation, Haier Biomedical, Philipp Kirsch GmbH, Leibherr Group, Inc., and Helmer Scientific.

 

Biomedical Refrigerators Market

 

On the basis of product type, the biomedical refrigerator market:

Blood Bank Refrigerators

Laboratory Refrigerators

 

On the basis of end user, the biomedical refrigerator market:

Hospitals

Pharmacies

Diagnostic Centers

Research Laboratories

Blood Banks

 

For More Information, Browse Full Report Here: https://www.coherentmarketinsights.com/ongoing-insight/biomedical-refrigerators-market-381

 

About Coherent Market Insights:

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

Contact Us:

 

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Single-Use Medical Device Reprocessing Market Report Puts Limelight On Opportunities By 2026

Single-use medical device reprocessing is the concept of sterilizing, repackaging, testing, and manufacturing a used product. There is no clear definition for the term single-use device and it is entirely based upon the end user perception. Reprocessing of single-use device is acceptable, if the device is properly sterilized while keeping its physical and technological functionalities intact. Single-use medical device reprocessing is done in two ways: third party processing and in-hospital processing. Third party processing is considered to be a better option, as regulatory authorities are able to impose strict regulations for validation and quality assurance purpose.

 

Download PDF Brochure of This Business Report @ https://www.coherentmarketinsights.com/insight/request-pdf/364

 

Single-use medical device reprocessing is gaining popularity as it helps to reduce hospital waste and allows for major cost savings. For instance, Kaiser Permanente, which is an integrated delivery network based in U.S., saved US$ 11 million on an annual basis by reprocessing of single-use devices. Reprocessing enables the hospitals to purchase the same device at a lower price in comparison to the cost of original equipment, which eventually leads to cost savings. Practice Green Health, an NGO providing environmental solutions to the healthcare sector, quoted that single-use medical device reprocessing prevented the entry of 10,000 tons of medical waste during 1997–2007, by processing an estimated 50 million devices. Single-use medical device reprocessing market is poised to grow significantly, as hospitals realize potential cost savings and its ability to reduce environmental hazards.

 

Cost constraints for Hospitals and positive environmental impact will drive growth of the single-use medical device reprocessing market

 

Hospitals across the globe are facing cost pressures due to rise in price of original medical equipment. In the U.S., Obamacare and its associated guidelines might get repealed with the change in government. This could lead to low third-party reimbursement for hospitals, in turn influencing them to adopt cost saving initiatives such as single-use medical device reprocessing. The biggest advantage is that hospitals can reduce the cost associated with medical device to 50%, which becomes a crucial factor when dealing with expensive devices such as catheter and cardiac ablation devices. At present, 250 medical devices are already being processed with 10% of medical devices eligible for single-use medical device reprocessing. In terms of environmental protection, hospitals are able to reduce the medical waste to an estimated 50% by the use of single-use medical device reprocessing. Medical waste treatment not only puts enormous cost pressure on hospitals, but in countries such as U.S., China and Japan, it has become a full-fledged industry.

 

North America is estimated to be the growth pocket for single-use medical device reprocessing market

 

U.S. has the biggest healthcare system in the world with government spending an estimated 30% of annual budget on healthcare. U.S. is also home to large-sized hospitals such as Cleveland Clinic, Mount Sinai Hospital, Beth Israel Deaconess Medical Centre and Johns Hopkins Hospital. These hospitals are subject to meeting sustainability goals and contain costs at the back of recession. For instance, in 2007, 45% of U.S. hospitals entered into an agreement with third-party processing companies and this number increased to 70% in 2008 due to severe economic crisis. Single-use medical device reprocessing is subject to FDA and required third-party processing companies to maintain quality standards in accordance with the original equipment. FDA formulated stringent regulation to create standardization and avoid infections related to the reuse of single-use devices. FDA has set up a grievance mechanism for reporting of adverse events related to use of single-use device which in turn reinforces accountability.

 

Single-use medical device reprocessing market is in nascent stage with few players dominating the market

 

The key players in the single-use medical device reprocessing market are Stryker Corporation, Medline ReNewal, Centurion Medical Products Corporation, Midwest Reprocessing Center, SterilMed Inc., Vanguard AG and Hygia Health Services Inc, among others. These players have successfully demonstrated the impact of single-use medical device reprocessing on cost savings and environmental protection. These companies will benefit in a large manner as the regulatory scenario becomes established in Europe and Asia Pacific.

 

Browse Complete Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/single-use-medical-device-reprocessing-market-364

 

About Coherent Market Insights:

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

Contact Us:

 

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Latest Trends of Pyrogen Testing Market 2018 Opportunity Assessment By 2026

Pyrogen testing is detection of pyrogen in pharmaceutical drugs and devices. The contaminated devices or drugs when introduced in body can cause fever, shock, inflammation, and other problems. Pyrogen testing consists of kits, reagents, and instruments, which enables pyrogen and endotoxins detection by in-vitro methods and minimizes the usage of animal testing.

 

Ask for Sample Copy of Research @ https://www.coherentmarketinsights.com/insight/request-sample/243

 

Market Dynamics

 

Increasing research and development in the field of pyrogen testing and advancements in technology for detection of endotoxin is a major factor driving pyrogen testing market growth. According to the Pharma R&D Annual Review, 2018, an estimated drug count in 2017 was around 14,872, while in 2018 it was around 15,267, resulting in an overall pipeline growth by 2.7% in 2018. Stringent government regulations and rising focus on in-vitro testing for detection of pyrogen is one of the major factors boosting growth of the market. For instance, in June 2012, the U.S. Food and Drug Administration (FDA) provided guidelines for pyrogen and endotoxin testing to industries.

 

The global pyrogen testing market size was valued at US$ US$ 689.9 million in 2017, and is expected to exhibit a CAGR of 12.4% over the forecast period (2018 – 2026).

 

Increasing demand for testing of pyrogen contamination in medical devices and drugs is expected to propel growth of the pyrogen testing market

 

Pyrogen testing is used in detection of pyrogen contamination in pharmaceutical dosage forms and medical devices. Pyrogen contaminated injections post administration can cause temperature dysregulation (fever), bodyache, inflammation, shock, multiorgan failure, and other life threatening problems.

 

Moreover, increasing research and development of therapeutic drugs and medical devices is propelling growth of the pyrogen testing market over the forecast period. According to the United Nations Educational, Scientific and Cultural Organization (UNESCO), November 2016, an estimated US$ 1.7 trillion of global spending in research and development for various medical applications. Moreover, the U.S. Food and Drug Administration (FDA) and its Center for Drug Evaluation and Research (CDER), has approved around 59 novel drugs in 2018 compared to 46 approvals of new molecule entities in 2017.

 

Key Players

 

Major players operating in the global pyrogen testing market include Thermo Fisher Scientific, Merck KGaA, Lonza Group, Associates of Cape Cod Inc., Charles River Laboratories Inc., GenScript, WuXi PharmaTech (Cayman), Inc., bioMérieux, Wako Chemicals USA, Inc., Sanquin, Ellab A/S, and Pyrostar

 

Detailed Segmentation:

 

Global Pyrogen Testing Market, By Test Type:

Limulus Amoebocyte Lysate (LAL) Test

TAL Test

Monocyte Activation Test (MAT)

Rabbit Pyrogen Test (RPT)

Recombinant Factor C Assay (rFC)

 

Global Pyrogen Testing Market, By Product Type:

Instruments

Kits

Reagents

 

Browse Complete Research Report @ https://www.coherentmarketinsights.com/market-insight/pyrogen-testing-market-243

 

About Coherent Market Insights:

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

Contact Us:

 

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Cystic Fibrosis Market Higher Mortality Rates by 2026

Cystic fibrosis (CF) is a genetic disorder that usually affects the lungs and may also affect the pancreas, kidneys, liver, and intestine. Long-term repercussions including difficulty in breathing and coughing as a result of recurrent lung infections can be seen in CF. Some of the other signs and symptoms include sinus infections, poor growth, infertility in males, fatty stool, and guild of the fingers and toes. Different individuals may have diverse degrees of symptoms. CF is chiefly inherited as an autosomal recessive gene. It is triggered by mutations in both the copies of the gene for CFTR or cystic fibrosis transmembrane conductance regulator protein. Individuals with a single copy are carriers. Cystic fibrosis transmembrane conductance regulator protein is involved in the production of digestive fluids, mucus, and sweat. When the protein is not functional, secretions otherwise thin become thick. The ailment is mostly diagnosed by genetic testing and sweat test.

 

Get In-Depth Sample Copy of Research @ https://www.coherentmarketinsights.com/insight/request-sample/236

 

Over the last few years, advancements in technology have resulted in a shift in research and development towards treatments that target the fundamental cause of the disease by targeting the CFTR function. Moreover, there is an affinity towards licensing the products, and for that reason alliances are being made by a number of biotechnology and pharmaceutical manufacturers, since the majority of the treatments for cystic fibrosis are developed by smaller manufacturers. The increase in licensing activity along with the rise in the number of new partnerships will encourage the smaller companies to continue their research work thereby giving a positive momentum to the cystic fibrosis market.

 

In spite of significant advancement in cystic fibrosis therapeutics, individuals suffering from CF face significant unmet needs owing to the deficiency of restorative therapies, inadequate choice of mucolytic treatments, and the unvarying fight alongside severe lung infection that needs the expansion of novel antibiotics. These factors are likely to drive the growth of the cystic fibrosis market during the forecast period.

 

High prevalence of genetic diseases including CF will drive the overall cystic fibrosis market

 

According to Netwellness, a community service provider, 3 to 4% of the babies are born with genetic disorders. This number is poised to rise in the coming years, especially in the emerging economies of Asia pacific such as China and India owing to high birth rate observed in these regions. As the number of cases of CF rises, so will the demand for CF treatment, thereby augmenting the growth of the overall cystic fibrosis market during the forecast period.

 

On the basis of geography North America held the maximum market share in the cystic fibrosis market globally. Constructive and favorable regulations and policies as well as high availability of sophisticated healthcare facilities and rising approvals of drugs for treating CF are likely to propel the growth of the cystic fibrosis industry in this region.

 

Competitor Landscape

 

Some of the key players operating in the global cystic fibrosis market are AbbVie, Inc., Aradigm, Aurora Biosciences, Bayer AG, Demegen, EryDel, Genentech, Inc., InDex Pharmaceuticals, ManRos Therapeutics, Novartis AG, Polydex Pharmaceuticals, and F. Hoffmann-La Roche AG.

 

Cystic fibrosis market Taxonomy -

 

On the basis of therapy type, the global market is classified into:

 

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators

Protein Transcription Modulators

Pancreatic Enzyme Products (PEP)

Other therapies

 

Browse Full Report @ https://www.coherentmarketinsights.com/ongoing-insight/cystic-fibrosis-market-236

 

About Coherent Market Insights:

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

Contact Us:

 

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Candidiasis Market to Witness Steady Growth Rate During 2018 to 2026

Candidiasis is a type of infection caused due to candida—an yeast and also classified as fungus, which is present in the human body. It is usually present in places like mouth, belly, and on the skin. The overgrowth of these leads to an infection. This dormant yeast can lead to candida infection at any stage in a person’s life and is closely linked to the immunity level of the person. There are various types of infections caused due to candidiasis, such as thrush/ oropharyngeal candidiasis, genital yeast infection/ invasive infection, and cutaneous candidiasis. Thrush/ oropharyngeal candidiasis affects the mouth or throat; genital yeast infection affects the vagina; and cutaneous candidiasis is the infection of the skin. When the infection enters into the blood stream, the condition is called Candidemia. Candidiasis can be diagnosed by physical observation. These conditions are usually treated using over-the-counter antifungal medicines and also specific prescription-based antifungal medicines.

 

Download PDF Brochure of This Business Report @ https://www.coherentmarketinsights.com/insight/request-pdf/229

 

Increasing consumer awareness about candidiasis and growing number of treatment options are major factors fueling growth of the candidiasis market. Conversely, dearth of R&D activities, low product availability, and easy access to alternative treatment methods such as use of herbal medicines inhibits growth of the candidiasis market.

 

Rising awareness regarding the infection and increasing patient pool to favor the growth of Candidiasis market

 

Rising awareness about the infections is expected to cause the growth of candidiasis market. Increasing focus of various governments in the APAC region, such as in highly populous China and India, on improving the healthcare infrastructure, along with increasing consumer awareness about the condition is expected to position the region on a high growth trajectory in the global candidiasis industry over the forecast period (2016–2024). Candidiasis are treated using various treatment option such as oral medication, injection, and ointments. Candidiasis can infect males, females and also newborn babies. The condition is notoriously hard to treat in people suffering from diabetes, cancer, AIDS, and also pregnant women. As per stats released by Centers for Disease Control and Prevention (CDC), around 75% of would suffer from at least one vaginal candida infection in their whole life, while 40-45% would suffer twice or more.

 

Developed Regions Growth Engine of Candidiasis Market

 

In developed countries, increasing number of organ transplantation, use of catheters, artificial valves, and joints causing to growth of candida infection. The North America and Europe regions account for the largest market share, due to high awareness about the infection, wide availability of treatment and easy access to OTC antifungal drugs creates a highly conducive environment for growth of the market. Azole Drugs holds large market share, with products such as Vfend, Noxafil, and Diflucan being highly preferred among the masses.

 

Major Key Players

 

The major market players in Candidiasis market are Bayer, Teva Pharmaceuticals, Stellar Pharma, Pfizer, Wockhardt, Glenmark Pharmaceuticals, Ranbaxy, Taro Pharmaceuticals, and Bristol Laboratories, among others.

 

Candidiasis Market Taxonomy:

 

This market is segmented by as follows-

 

By Route of Administration:

Oral

Parenteral

Topical

 

By Type of Infection:

Thrush/ oropharyngeal candidiasis

Genital Yeast Infection/ Invasive infection

Cutaneous Candidiasis

 

Browse In-Depth Analysis Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/candidiasis-market-229

 

About Coherent Market Insights:

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

Contact Us:

 

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Kidney Dialysis Equipment Market Current and Future Scenario of The Market

Chronic kidney disease (CKD) is a chronic condition that seriously affects the quality of life of the patient. Kidney dialysis is the preferred mode of treatment for severe conditions wherein both kidneys are damage, though the technique is also used occasionally for treatment of patients with just one damaged kidney. Furthermore, there are various renal disorders and normal causes that cause total renal failure. However, there is no single cause that deteriorates the kidney function. The damage is usually irreversible and can lead to life threatening problems. To mitigate such problems, kidney transplant is recommended. This, however, requires the same blood donor of the kidney to maintain the compatibility of the transplant with the other vital organs in the body. In some cases, dialysis or transplantation may become necessary, which can further favor the rise in growth in kidney dialysis equipment market.

 

Ask for Sample Copy of Research @ https://www.coherentmarketinsights.com/insight/request-sample/222

 

Diabetes mellitus is considered as the most common cause of chronic kidney disease that may lead to increase in demand for kidney dialysis. According to Scottish Intercollegiate Guidelines Network, in 2008, the average prevalence has been reported at 11% in the U.S. and Europe that are excluding those on dialysis or with a functioning transplant. Growth of geriatric population is one of the major reasons expected to support growth of the kidney dialysis equipment market in the near future. Large number of people in their old age are more prone to suffer from kidney failure.

 

The global kidney dialysis equipment market was valued at US$ 13,930.3 Mn in 2015 and is expected to witness a robust CAGR of 6.6% during the forecast period (2016 – 2024).

 

Demographic Shift of major chunk of population towards increasing geriatric population

 

Elderly population are more prone to various disease due to diminished level of immunity and other co-morbid disease conditions. Diabetes mellitus is a very common disorder that is the initiator for various unwanted disease conditions. One of the most frequently arising condition is kidney failure. The unnoticed and improper care of the diabetic patient may lead to abnormal functioning of kidney and in severe cases total shut down of the organ. Kidney dialysis is a process in which an external machine acts as the kidney for the filtration of body fluids. Furthermore, the dialysis works on various sequential methods such as proper testing of vitals of the patient that is necessary for maintaining the appropriate glomerular filtration rate. Dialysis procedure helps in maintaining the proper standards of the body fluids and other important kidney functions such as waste removal, removal of extra water and salt to prevent them from building up in the body that ensure safe level of certain chemicals such as potassium, sodium and bicarbonate in the blood, which helps in controlling the blood pressure.

 

Competitive Landscape

 

Key companies covered as a part of this study include Baxter International, Inc., Fresenius Medical Care AG & Co., Nipro Corporation, B. Braun Melsungen, Nikkiso Co, Ltd., Asahi Kasei Corporation and NxStage Medical, Inc.

 

Detailed Segmentation:

 

Global Kidney Dialysis Equipment Market, By Equipment:

Hemodialysis

Machines

Dialyzers

Bloodlines

Concentrates and dialysis solutions

Others (Water treatment systems, accessories)

Peritoneal dialysis

Machines

Dialysates

Catheters

Transfer sets

Continuous renal replacement therapy (CRRT)

 

Browse In-Depth Analysis Research Report @ https://www.coherentmarketinsights.com/market-insight/kidney-dialysis-equipment-market-222

 

About Coherent Market Insights:

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

Contact Us:

 

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Kidney Dialysis Equipment Market Increase In Transactional And Analytical Needs 2024

Chronic kidney disease (CKD) is a chronic condition that seriously affects the quality of life of the patient. Kidney dialysis is the preferred mode of treatment for severe conditions wherein both kidneys are damage, though the technique is also used occasionally for treatment of patients with just one damaged kidney. Furthermore, there are various renal disorders and normal causes that cause total renal failure. However, there is no single cause that deteriorates the kidney function. The damage is usually irreversible and can lead to life threatening problems. To mitigate such problems, kidney transplant is recommended. This, however, requires the same blood donor of the kidney to maintain the compatibility of the transplant with the other vital organs in the body. In some cases, dialysis or transplantation may become necessary, which can further favor the rise in growth in kidney dialysis equipment market.

 

Ask for Sample Copy of Research @ https://www.coherentmarketinsights.com/insight/request-sample/222

 

Diabetes mellitus is considered as the most common cause of chronic kidney disease that may lead to increase in demand for kidney dialysis. According to Scottish Intercollegiate Guidelines Network, in 2008, the average prevalence has been reported at 11% in the U.S. and Europe that are excluding those on dialysis or with a functioning transplant. Growth of geriatric population is one of the major reasons expected to support growth of the kidney dialysis equipment market in the near future. Large number of people in their old age are more prone to suffer from kidney failure.

 

The global kidney dialysis equipment market was valued at US$ 13,930.3 Mn in 2015 and is expected to witness a robust CAGR of 6.6% during the forecast period (2016 – 2024).

 

Demographic Shift of major chunk of population towards increasing geriatric population

 

Elderly population are more prone to various disease due to diminished level of immunity and other co-morbid disease conditions. Diabetes mellitus is a very common disorder that is the initiator for various unwanted disease conditions. One of the most frequently arising condition is kidney failure. The unnoticed and improper care of the diabetic patient may lead to abnormal functioning of kidney and in severe cases total shut down of the organ. Kidney dialysis is a process in which an external machine acts as the kidney for the filtration of body fluids. Furthermore, the dialysis works on various sequential methods such as proper testing of vitals of the patient that is necessary for maintaining the appropriate glomerular filtration rate. Dialysis procedure helps in maintaining the proper standards of the body fluids and other important kidney functions such as waste removal, removal of extra water and salt to prevent them from building up in the body that ensure safe level of certain chemicals such as potassium, sodium and bicarbonate in the blood, which helps in controlling the blood pressure.

 

Competitive Landscape

 

Key companies covered as a part of this study include Baxter International, Inc., Fresenius Medical Care AG & Co., Nipro Corporation, B. Braun Melsungen, Nikkiso Co, Ltd., Asahi Kasei Corporation and NxStage Medical, Inc.

 

Detailed Segmentation:

 

Global Kidney Dialysis Equipment Market, By Equipment:

Hemodialysis

Machines

Dialyzers

Bloodlines

Concentrates and dialysis solutions

Others (Water treatment systems, accessories)

Peritoneal dialysis

Machines

Dialysates

Catheters

Transfer sets

Continuous renal replacement therapy (CRRT)

 

Browse In-Depth Analysis Research Report @ https://www.coherentmarketinsights.com/market-insight/kidney-dialysis-equipment-market-222

 

About Coherent Market Insights:

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

Contact Us:

 

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Remote Patient Monitoring Devices Market Detailed Analysis and Forecast to 2025

Remote patient monitoring devices allow for digital collection of medical health data from one location and electronically transmit the information to health care providers to another location for recommendation and assessments. The monitoring devices collect wide range of healthcare data from the point of care, which includes blood pressure, blood oxygen levels, heart rates, electrocardiograms, vital signs and blood sugar. The data obtained through the devices is then transmitted to health professionals in facilities such as hospitals, intensive care units and nursing facilities. Healthcare is revolutionized by Health Information Technologies (HITs) by becoming mainstream tools to assist patients in decision-making and self-monitoring and consequently, driving a shift towards a care model centered on the use of digital and web-based tools.

 

Ask Sample Copy of This Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/215

 

The global remote patient monitoring devices market is estimated to be valued at US$ 856.8 million in 2017 and is expected to witness a CAGR of 7.1 % during the forecast period (2017 – 2025).

 

Market Dynamics

 

The market is gaining significant traction due to rising prevalence rate of hypertension and diabetes. Management of these chronic conditions include a lifelong collaboration with the healthcare professionals. According to the World Health Organization 2012, an estimated 1.5 million deaths were directly caused by diabetes and another 2.2 million deaths were attributable to hyperglycemia or high blood glucose levels. The technological innovations and developments of remote monitoring products are contributing to the market growth. For instance, the FDA approval of CGM remote mobile communications device Dexcom SHARE, an accessory of Dexcom G4 PLATINUM Continuous Glucose Monitoring System, uses a secure wireless connection to transmit the glucose levels of a diabetic. With Dexcom SHARE, the glucose data can be easily monitored by parents and personal caregivers from a remote location.

 

Increasing prevalence of respiratory disorders drives the growth of remote patient monitoring devices market

 

The remote patient monitoring devices market is expected to grow drastically owing to the government regulations to control the rising healthcare costs, the technological innovations and developments of efficient self-monitoring products. The Patient Protection and Affordable Care Act, also known as Obamacare was implemented under the Hospital Readmissions Reduction Program by U.S. government to impose penalties to hospitals. According to the penalty, government had reduced up to 1% in the Medicare payment per patient for hospital readmission within 30 days in 2013, thereby, accelerating the growth of remote patient monitoring devices by the healthcare professionals. According to the Biomed Central Respiratory Research 2016, asthma and chronic obstructive pulmonary disease (COPD) are common chronic obstructive lung disorders characterized by variable airflow limitation and airway hyper responsiveness, affecting over 25 million people in the U.S.

 

Top Market Companies

 

Key companies covered as a part of this study include Abbott Laboratories, GE Healthcare, Omron Healthcare, Medtronic, St. Jude Medical, Smiths Medical, Philips Healthcare, F. Hoffmann-La Roche Ltd. And Kokinklijke Philips N.V. and St. Jude Medical.

 

Detailed Segmentation:

 

Global Remote Patient Monitoring Devices Market, By Product Type:

Cardiac Monitors

Respiratory Monitors

Hematological Monitors

Vital Signs Monitors

Others

 

Global Remote Patient Monitoring Devices Market, By Application:

Cardiac Arrhythmia

Diabetes

Ischemic Diseases

Hypertension

Sleep Apnea

Chronic Respiratory Diseases

Hyperlipidemia

 

Browse Complete Research Report @ https://www.coherentmarketinsights.com/market-insight/remote-patient-monitoring-market-215

 

About Coherent Market Insights:

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

Contact Us:

 

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Bioelectronics Market Valuable Foresights to 2026

Bioelectronics is a branch of medical science that deals with the application of ideologies of biological sciences in electrical/electronic engineering. In simpler terms, bioelectronics is the combination of biology and electronics. This is an essential emerging field in medicine. Bioelectronics has led to the expansion of various devices such as the pacemaker and a wide variety of therapeutic imaging devices that are easily accessible. The nervous system transmits an endless number of signals to carry out various functions of the human body. This creates a highly lucrative growth prospect for the study of bioelectronics and the related market is projected to flourish over the next few years.

 

Download PDF Brochure of This Business Report @ https://www.coherentmarketinsights.com/insight/request-pdf/206

 

Some of the major tools associated with bioelectronics are bioelectromagnetics, robotics, sensors, and neural networks. Bioelectronics have been making a huge impact in the medicinal field from its early days, however, bioelectronics’ role in medical science is likely to grow at an incredible pace during the forecast period, touching disparate healthcare specialties such as vision disorders and spinal injuries. Wide-ranging research and development activities related to bioelectronics will aid in the increasing health care market by facilitating on-site diagnosis as well. Apart from life sciences and medical research, it is used in ecological monitoring as well, with requirement for the latter anticipated to rise speedily in the forecast period, owing to growing danger of global warming around the globe.

 

Growing diabetic population and the increasing prevalence of heart diseases will drive the overall bioelectronics market

 

According to the Heart Foundation, in 2011, heart and other cardiovascular diseases led to 787 thousand fatalities in the U.S. alone. Moreover, as per International Diabetic Federation (IDF) around 415 million people suffered from diabetes in 2015. Since diabetic monitoring and control as well as heart failure patients need bioelectronics devices in the form of glucose monitoring devices, and artificial pacemakers, respectively, the market for bioelectronics product is likely to experience a huge surge in demand during the forecast period. This is attributed to rise in the number of patients suffering from the aforementioned diseases.

 

North America held the maximum share of the bioelectronics market, owing to large number of applications in various healthcare segments. Rising occurrence of several grave diseases due to sedentary lifestyle; existence of large number of R&D facilities; and escalating adoptability of refined and advanced products by healthcare professionals, clinicians and patients, the bioelectronics market will see a significant growth momentum in this region. Asia Pacific is expected to observe a considerable growth due to improvement in healthcare infrastructure as well as speedy economic growth in the course of the forecast period.

 

Top Key Players

 

Some of the key players operating in the global bioelectronics market are F. Hoffmann-La Roche Ltd, Abbott laboratories, LifeSensors, Siemens Healthcare, Nova Biomedical Corporation and AgaMatrix. Some of the other companies operating in the market are Bioelectronics Corporation, Sotera wireless, Beckman Coulter, Bodymedia, Avago, Danaher Corporation, Medtronics, Omnivision Technologies, and Roche, Sensirion.

 

Bioelectronics Market Taxonomy

 

On the basis of product type, the market is classified into:

 

Electrochemical biosensors

Piezoelectric biosensors

Thermal biosensors

Optical biosensors

 

On the basis of application, the global market is classified into:

 

Fabrication Templates

Biochips

Implantable Devices

Prosthetic

Artificial Organs

Pills

Surgical

Biofuel Cells

Molecular Motors

 

Browse In-Depth Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/bioelectronics-market-206

 

About Coherent Market Insights:

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

Contact Us:

 

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Hearing Protection Devices Market Recreational Structure Analysis for the Period 2024

One in 10 people in the U.S. suffer from hearing impairment, which later troubles an individual’s ability to recognize and understand the normal speech. Intense sound exposure is one of the most general causes of impaired hearing. This can be experience at industrial area, traffic, manufacturing site, and mines. The workers working in these premises are subjected to high noise levels, which can lead to long-term hearing loss. There are various basic effective hearing conservation programs conducted at various industrial and construction premises, though these rely on use of hearing protection devices rather than on means to reduce exposure to high noise levels. A data analysis by National Health and Nutrition Examination Survey in the U.S. stated that the prevalence of hearing impairment between 2000 and 2012 among the teenage group was 5.3-6.0%. Some of the occupational decibel levels and incidence rates of hearing loss at age 50 at manufacturing site and farming is 105dB and hearing loss at age 50 is 30% and 36%, respectively. At construction sites, the decibel level is 120dB and around 60% of people experience hearing loss in this sector.

 

The global hearing protection market was valued at US$ 908.3 million in 2015 and is expected to witness a CAGR of 10.8% during the forecast period (2016 – 2024).

 

Ask Sample Copy of Research @ https://www.coherentmarketinsights.com/insight/request-sample/199

 

Market Dynamics

 

A study conducted by Noise and Health organization in Accura, Ghana, a total of 101 mill workers were examined and found that 23.7% were identified with the hearing loss symptoms. According to the Bureau of Labor Statistics’ (BLS) Quarterly Census of Employment and Wages, there are of approximately 74% of hearing loss cases in the U.S. due to manufacturing. Furthermore, approximately 12 million workers in the country are involved in the manufacturing sector. Bureau of Labor Statistics’ (BLS) explains that hearing loss is one of the factor of any individual illness among the manufacturing workers. According to Survey of Occupational Injuries and Illnesses, in the U.S., in 2012, hearing loss accounted for 12% or 18, 500 cases of all recordable cases. At the state level, Ohio Survey of Occupational Injuries and Illnesses data for 2012 recorded a total number hearing loss factors was in private sector industries itself be around 5,000 cases. Out of 5000 cases, hearing loss cases reported in Ohio’s manufacturing industries were around 800 to 900 days.

 

Around 60% of operating engineer working at construction industry report that they have trouble in understanding speech

 

An estimated one-third of the all impaired hearing cases are related to noise exposure. Occupational noise exposure is the one of the most common causes of noise induced hearing loss in the U.S. In 2013, around 10% i.e. around 22 million people of age group 20 to 69 years in the U.S. suffered from permanent hearing loss as they were exposed to high or loud noise at construction and/or respective work environment. Specifically, increasing number of workers at construction or manufacturing site and increasing adoption of hearing control devices in developed regions to boost growth of the hearing protection market. Noise-induced hearing loss is one of the prominent diseases in the U.S. and the second-largest self-reported occupational illness or injury. Certain jobs that involve loud noise exposure include mining, tunneling, drilling, heavy engineering, operation carried by powerful combustion engines such as trucks, construction vehicles, etc. With the increase in exposure of workers to such noise leads to increase prevalence of impaired hearing.

 

Competitive Analysis

 

Key companies covered as a part of this study include 3M, Starkey Laboratories India Pvt. Ltd, Honeywell International Inc, Hellberg Safety Ab, Amplifon., Dynamic Ear Company, Centurion Safety Products Ltd., Sonomax Technologies Inc, Siemens Healthcare GmbH, ADCO Hearing Products Inc, and Elvex Corporation and Moldex-Metric Inc.

 

Detailed Segmentation:

 

Global Hearing Protection Devices Market, By Product:

Ear Plugs

Earmuffs

Uniform Attenuation Earplugs

Hearing Bands

 

Global Hearing Protection Devices Market, By Protector:

Enclosure

Aural Insert

Super-aural Protectors

Circum-aural Protector

 

Browse In-Depth Research Report @ https://www.coherentmarketinsights.com/market-insight/hearing-protection-devices-market-199

 

About Coherent Market Insights:

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

Contact Us:

 

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com